BMJ Best Practice

参考文献

关键文献

Breech LL, Rock JA. Leiomyomata uteri and myomectomy. In: Rock JA, Jones III HW, eds. Te Linde's operative gynecology, 9th edition. Philadelphia: JB Lippincott Co.; 2003:753-798.

Marshall LM, Spiegelman D, Barbieri RL, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol. 1997;90:967-973.

American Congress of Obstetricians and Gynecologists. Alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol. 2008;112:387-400.

参考文章

1.  Breech LL, Rock JA. Leiomyomata uteri and myomectomy. In: Rock JA, Jones III HW, eds. Te Linde's operative gynecology, 9th edition. Philadelphia: JB Lippincott Co.; 2003:753-798.

2.  Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990;94:435-438.

3.  Droegemueller W. Benign gynecologic conditions. In: Mishell Jr DR, Stenchever MA, Droegemueller W, et al, eds. Comprehensive gynecology, 3rd edition. St. Louis: Mosby-Yearbook Inc.; 1997:467-516.

4.  Sciarra J, Dilts PV Jr (eds). Gynecology and obstetrics. Philadelphia, PA: JB Lippincott; 1986.

5.  Payson M, Leppert P, Segars J. Epidemiology of myomas. Obstet Gynecol Clin North Am. 2006;33:1-11.

6.  Marshall LM, Spiegelman D, Barbieri RL, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol. 1997;90:967-973.

7.  Day Baird D, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100-107.

8.  American Congress of Obstetricians and Gynecologists. ACOG practice bulletin: surgical alternatives to hysterectomy in the management of leiomyomas. Int J Gynaecol Obstet. 2001;73:285-293.

9.  Townsend DE, Sparkes RS, et al. Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis of glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol. 1970;107:1168-1173.

10.  Rein MS, Friedman AJ, Barbieri RL, et al. Cytogenetic abnormalities in uterine leiomyomata. Obstet Gynecol. 1991;77:923-926.

11.  Mashal RD, Schoenberg-Fejzo ML, Friedman AJ, et al. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in leiomyomata development. Genes Chromosom Cancer. 1994;11:1-6.

12.  Rein MS, Barbieri RL, Friedman AJ. Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol. 1995;172:14.

13.  Leppert PC, Catherino WH, Segars JH, et al. A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays. Am J Obstet Gynecol. 2006;195:415-420.

14.  Buttram VC, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981;36:433-445.

15.  Stewart EA, Nowak RA. Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era. Human Repr Update. 1996;2:295-306.

16.  Ross RK, Pike MC, Vessey, MP, et al. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. BMJ. 1986;293:359-362.

17.  Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect. 2003;111:1037-1054.

18.  Wise LA, Palmer JR, Stewart EA, et al. Age-specific incidence rates for self-reported uterine leiomyomata in the black women's health study. Obstet Gynecol. 2005;105:563-568.

19.  Faerstein E, Szklo M, Rosenshein N. Risk factors for uterine leiomyoma: a practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking. Am J Epid. 2001;153:1-10.

20.  Boynton-Jarrett R, Rich-Edwards J, Malspeis S, et al. A prospective study of hypertension and risk of uterine leiomyomata. Am J Epid. 2005;171:628-638.

21.  Chiaffarino F, Parazzini F, La Vecchia C, et al. Diet and uterine myomas. Obstet Gynecol. 1999;94:395-398.

22.  Maruo T, Ohara N, Wang J, et al. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update. 2004;10:207-220.

23.  Baron JA. Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. Br Med Bull. 1996;52:58-73.

24.  Wise LA, Palmer JR, Harlow BL, et al. Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the Black Women's Health Study. Hum Reprod. 2004;19:1746-1754.

25.  Wise LA, Palmer JR, Harlow BL, et al. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol. 2004;15:159:113-123.

26.  Critchley HOD, Warner P, Less AJ, et al. Evaluation of abnormal bleeding: comparison of three outpatient procedures within cohorts defined by age and menopausal status. Health Tech Assess. 2004;8:1-46.

27.  Hatasaka H. The evaluation of abnormal uterine bleeding. Clin Obstet Gynecol. 2005;48:258-273.

28.  Fedele L, Bianchi S, Dorta M, et al. Transvaginal ultrasonography versus hysteroscopy in the diagnosis of uterine submucous myomas. Obstet Gynecol. 1991;77:745-748.

29.  American Congress of Obstetricians and Gynecologists. ACOG practice bulletin number 65: management of endometrial cancer. Obstet Gynecol. 2006;107:952.

30.  DiSaia PJ, Creasman WT. Clinical gynecologic oncology, 6th ed. St Louis: Mosby, Inc.; 2002:137-171.

31.  Creasman WT. Malignant tumors of the uterine corpus. In: Rock JA, Jones III HW, eds. Te Linde's operative gynecology, 9th ed. Philadelphia: JB Lippincott Co.; 2003:1445-1486.

32.  Clevenger-Hoeft M, Syrop CH, Stovall DW. Sonohysterography in premenopausal women with and without abnormal bleeding. Obstet Gynecol. 1999;94:516-520.

33.  American Congress of Obstetricians and Gynecologists. Technology assessment: saline infusion sonohysterography. Int J Gynaecol Obstet. 2004;84:95-98.

34.  Cicinelli E, Romano F, Anastasio PS, et al. Transabdominal sonohysterography, transvaginal sonography, and hysteroscopy in the evaluation of submucous myomas. Obstet Gynecol. 1995;85:42-47.

35.  Dueholm M, Lundorf E, Olesen F. Imaging techniques for evaluation of the uterine cavity and endometrium in premenopausal patients before minimally invasive surgery. Obstet Gynec Survey. 2002;57:389-403.

36.  Leone FP, Lanzani C, Ferrazzi E. Use of strict sonohysterographic methods for preoperative assessment of submucous myomas. Fertil Steril. 2003;79:998-1002.

37.  Davis PC, O'Neill MJ, Yoder IC, et al. Sonohysterographic findings of endometrial and subendometrial conditions. Radiographics. 2002;22:803-816.

38.  Gaucherand P, Piacenza JM, Salle B, et al. Sonohysterography of the uterine cavity: preliminary investigations. J Clin Ultrasound. 1995;23:339-348.

39.  Alatas C, Aksoy E, Akarsu C, et al. Evaluation of intrauterine abnormalities in infertile patients by sonohysterography. Hum Reprod. 1997;12:487-490.

40.  Thomassin-Naggara I, Darai E, Nassar-Slaba J, et al. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma. J Comput Assist Tomogr. 2007;31:236-242.

41.  Maizlin ZV, Vos PM, Cooperberg PL. Is it a fibroid? Are you sure? Sonography with MRI assistance. Ultrasound. 2007;23:55-62.

42.  Wolfman DJ, Ascher SM. Magnetic resonance imaging of benign uterine pathology. Top Magn Reson Imaging. 2006;17:399-407.

43.  Macura KJ. Role of magnetic resonance imaging in the assessment of the female pelvis. Top Magn Reson Imaging. 2006;17:363-364.

44.  Curtis M, Hopkins MP, Zarlingo T, et al. Magnetic resonance imaging to avoid laparotomy in pregnancy. Obstet Gynecol. 1993; 82:833-836.

45.  Kido AK, Togashi K, Koyama T, et al. Diffusely enlarged uterus: evaluation with MR imaging. Radiographics. 2003;23:1423-1439.

46.  Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2004;104:393-406.

47.  Broder MS, Goodwin S, Chen G, et al. Comparison of long-term outcomes of myomectomy and uterine artery embolization. Obstet Gynecol. 2002;100:864-868.

48.  Pritts EA. Fibroids and infertility: a systematic review of the evidence. Obstet Gynecol Survey. 2001;56:483-491.

49.  Sanders B. Uterine factors and infertility. J Reprod Med. 2006;51:169-176.

50.  Salem S. The uterus and adnexa. In: Rumack CM, Wilson SR, Charboneau JW, eds. Diagnostic ultrasound, 2nd ed. Mosby-Year Book Inc.; 1998:519-573.

51.  Vitiello D, McCarthy S. Diagnostic imaging of myomas. Obstet Gynecol Clin North Am. 2006;33:85-95.

52.  Chambers JT, Chambers SK. Endometrial sampling: When? Where? Why? With what? Clin Obstet Gynecol.1992;35:28-39.

53.  Rajkotia K, Veeramani M, Macura KJ. Magnetic resonance imaging of adnexal masses. Top Magn Reson Imaging. 2006;17:379-397.

54.  American Congress of Obstetricians and Gynecologists. Alternatives to hysterectomy in the management of leiomyomas. Obstet Gynecol. 2008;112:387-400.

55.  Viswanathan M, Hartmann K, McKoy N, et al. Management of uterine fibroids: an update of the evidence. AHRQ evidence report/technology assessment no. 154. Evid Rep Technol Assess (Full Rep). 2007;1-122.

56.  US Food and Drug Administration. Updated laparoscopic uterine power morcellation in hysterectomy and myomectomy: FDA safety communication. November 2014. http://www.fda.gov (last accessed 28 December 2016).

57.  Tropeano G, Amoroso S, Scambia G. Non-surgical management of uterine fibroids. Hum Reprod Update. 2008;14:259-274.

58.  Cheng MH, Wang PH. Uterine myoma: a condition amenable to medical therapy? Expert Opin Emerg Drugs. 2008;13:119-133.

59.  Olive DL, Lindheim SR, Pritts EA. Non-surgical management of leiomyoma: impact on fertility. Curr Opin Obstet Gynecol. 2004;16:239-243.

60.  Morris EP, Rymer J, Robinson J, et al. Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids. Fertil Steril. 2008;89:421-428.

61.  Lethaby AE, Vollenhoven BJ. An evidence-based approach to hormonal therapies for premenopausal women with fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22:307-331.

62.  Grigorieva V, Chen-Mok M, Tarasova M, et al. Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas. Fertil Steril. 2003;79:1194-1198.

63.  Varma R, Sinha D, Gupta JK. Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS): a systematic enquiry and overview. Eur J Obstet Gynecol Reprod Biol. 2006;135:9-28.

64.  Metwally M, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev. 2012;(11):CD003857.

65.  Jin C, Hu Y, Chen XC, et al. Laparoscopic versus open myomectomy: a meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol. 2009;145:14-21.

66.  Kongnyuy EJ, van den Broek N, Wiysonge CS. A systematic review of randomized controlled trials to reduce hemorrhage during myomectomy for uterine fibroids. Int J Gynaecol Obstet. 2008;100:4-9.

67.  Iverson RE Jr, Chelmow D, Strohbehn K, et al. Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas. Obstet Gynecol. 1996;88:415-419.

68.  Lefebvre G, VIlos G, Allaire C, et al. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2003;128:1-10.

69.  Fernandez H, Sefrioui O, Virelizier C, et al. Hysteroscopic resection of submucosal myomas in patients with infertility. Hum Reprod. 2001;16:1489-1492.

70.  Bajekal N, Li TC. Fibroids, infertility and pregnancy wastage. Hum Reprod Update. 2000;6:614-620.

71.  Di Spiezio Sardo A, Mazzon I, Bramante S, et al. Hysteroscopic myomectomy: a comprehensive review of surgical techniques. Hum Reprod Update. 2008;14:101-119.

72.  Royal College of Obstetricians and Gynaecologists (RCOG); British Society for Gynaecological Endoscopy. Best practice in outpatient hysteroscopy. (Green-top guideline; no. 59). London (UK): RCOG; 2011.

73.  American Congress of Obstetricians and Gynecologists. ACOG committee opinion: uterine artery embolization. Obstet Gynecol. 2004;103:403-404.

74.  Homer H, Saridogan E. Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. Fertil Steril. 2010;94:324-330.

75.  Carranza-Mamane B, Havelock J, Hemmings R, et al; Society of Obstetricians and Gynaecologists of Canada. The management of uterine fibroids in women with otherwise unexplained infertility. J Obstet Gynaecol Can. 2015;37:277-288.

76.  Gupta JK, Sinha A, Lumsden MA, et al. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2014;(12):CD005073.

77.  Lefebvre GG, Vilos G, Asch M. SOGC clinical practice guidelines. Uterine fibroid embolization (UFE). Number 150, October 2004. Int J Gynaecol Obstet. 2005;89:305-318.

78.  Rosero EB, Kho KA, Joshi GP, et al. Comparison of robotic and laparoscopic hysterectomy for benign gynecologic disease. Obstet Gynecol. 2013;122:778-786.

79.  Aarts JW, Nieboer TE, Johnson N, et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2015;(8):CD003677.

80.  Yoon SW, Lee C, Cha SH, et al. Patient selection guidelines in MR-guided focused ultrasound surgery of uterine fibroids: a pictorial guide to relevant findings in screening pelvic MRI. Eur Radiol. 2008;18:2997-3006.

81.  Jacoby AF. New and emerging treatments for uterine leiomyomas. Adv Stud Med. 2006;6:260-266.

82.  Zhang Y, Peng W, Clarke J, et al. Acupuncture for uterine fibroids. Cochrane Database Syst Rev. 2010;(1):CD007221.

83.  Liu JP, Yang H, Xia Y, et al. Herbal preparations for uterine fibroids. Cochrane Database Syst Rev. 2013;(4):CD005292.

84.  Li TC, Mortimer R, Cook ID. Myomectomy: a retrospective study to examine reproductive performance before and after surgery. Human Repro. 1999;14:1735-1740.

85.  Coronado GD, Marshall LM, Schwartz SM. Complications in pregnancy, labor and delivery, with uterine leiomyomas: a population-based study. Obstet Gynecol. 2000;95:764-769.

86.  Practice Committee of the American Society for Reproductive Medicine. Myomas and reproductive function. Fertil Steril. 2006;86(suppl 4):S194-S199.

87.  Casini ML, Rossi F, Agostini R, et al. Effects of the position of fibroids on fertility. Gynecol Endocrinol. 2006; 22:106-109.

使用此内容应接受我们的免责声明